ACADIA Pharmaceuticals Inc.
ACAD
$15.42
-$0.70-4.34%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 226.45M | 128.51M | 30.57M | -1.71M | -61.29M |
| Total Depreciation and Amortization | 15.88M | 12.31M | 11.46M | 10.65M | 5.55M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -88.77M | 66.36M | 57.99M | 59.17M | 54.30M |
| Change in Net Operating Assets | 4.16M | -4.44M | -19.49M | -4.40M | 18.13M |
| Cash from Operations | 157.72M | 202.73M | 80.53M | 63.71M | 16.70M |
| Capital Expenditure | -523.00K | -70.00K | -50.00K | -50.00K | -50.00K |
| Sale of Property, Plant, and Equipment | 146.52M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -176.53M | -152.97M | -36.42M | -174.51M | 32.05M |
| Cash from Investing | -30.54M | -153.04M | -36.47M | -174.56M | 32.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.85M | 10.31M | 22.79M | 24.71M | 25.13M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.85M | 10.31M | 22.79M | 24.71M | 25.13M |
| Foreign Exchange rate Adjustments | -94.00K | -46.00K | -8.00K | -11.00K | -18.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 133.93M | 59.96M | 66.84M | -86.15M | 73.81M |
